临床研究
两年结果后的左主冠状动脉急性冠脉综合征患者经皮冠状动脉介入
|
|
PSM之前 |
PSM后 |
| LMCA |
Non-LMCA |
价值 |
LMCA |
Non-LMCA |
价值 |
| (n= 155) |
(n= 6274) |
(n= 150) |
(n= 150) |
|
| 语法分数 |
|
|
|
|
|
|
| 之前的程序 |
20.11±9.98 |
11.34±7.83 |
< 0.001 |
19.85±9.89 |
19.89±9.88 |
0.970 |
| 手术后 |
2.91±5.29 |
3.32±5.67 |
0.368 |
2.80±5.28 |
4.49±6.72 |
0.016 |
| 无保护LMCA |
147 (94.8) |
- - - - - - |
- - - - - - |
142 (94.7) |
- - - - - - |
- - - - - - |
| Trivessel疾病,% |
21日(13.5) |
107 (1.7) |
< 0.001 |
13 (8.7) |
0 (0) |
< 0.001 |
| 总阻塞,% |
33 (21.3) |
1350 (21.5) |
0.946 |
32 (21.3) |
64 (42.7) |
< 0.001 |
| 穿刺网站,% |
|
|
|
|
|
|
| 股动脉 |
20 (12.9) |
431 (6.9) |
0.014 |
20 (13.3) |
18 (12.0) |
0.558 |
| 桡动脉 |
132 (85.2) |
5749 (91.6) |
|
127 (84.7) |
131 (87.3) |
|
| 其他方法 |
3 (1.9) |
94 (1.5) |
|
3 (2.0) |
1 (0.7) |
|
| PCI, % |
53 (34.2) |
570 (9.1) |
< 0.001 |
53 (35.3) |
55 (36.7) |
0.810 |
| IVUS用法,% |
71 (45.8) |
261 (4.2) |
< 0.001 |
71 (47.3) |
71 (47.3) |
1.000 |
| IABP用法,% |
18 (11.6) |
81 (1.3) |
< 0.001 |
18 (12.0) |
18 (12.0) |
1.000 |
| 成功的PCI, % |
152 (98.1) |
6166 (98.3) |
0.751 |
148 (98.7) |
148 (98.7) |
1.000 |
| PTCA, % |
60 (38.7) |
1024 (17.1) |
< 0.001 |
60 (40.0) |
59 (39.3) |
|
| 支架类型 |
|
|
|
|
|
|
| 百时美施贵宝,% |
0 (0) |
46 (0.8) |
0.285 |
0 (0) |
1 (0.7) |
1.000 |
| DES, % |
|
|
|
|
|
|
| 1 g-des |
17 (11.0) |
1150 (19.2) |
0.019 |
16 (10.7) |
13 (8.7) |
0.558 |
| 2 g-des |
59 (38.1) |
2706 (45.1) |
0.208 |
57 (38.0) |
53 (35.3) |
0.632 |
| BP-DES |
19日(12.3) |
957 (16.0) |
0.305 |
23日(15.3) |
17 (11.3) |
0.308 |
| 其他人 |
0 (0) |
88 (1.5) |
0.277 |
0 (0) |
1 (0.7) |
1.000 |
| 混合多个密不可分 |
0 (0) |
28日(0.5) |
1.000 |
0 (0) |
0 (0) |
1.000 |
|
|
|
值意味着±SD或n(%)。经皮冠状动脉介入之间语法=协同作用与紫杉和心脏手术;LMCA =左主冠状动脉;PCI =经皮冠状动脉介入;IVUS =血管内超声;IABP =主动脉内气囊泵;PTCA =经皮穿冠状血管成形术;百时美施贵宝=裸金属支架;DES =药物洗脱支架;1 g =第一代; 2G = second generation; BP = biodegradable polymer.
|
